TrialJournal of clinical immunology2016

Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases.

Mark Ballow et al.PubMed ↗Publisher ↗

No numbers read from the abstract.